Axogen
Yahoo Finance • 16 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. (“Axogen” or the “Company”) (NASDAQ: AXGN). Such investors are advised to contact Danielle Peyton at newaction@po... Full story
Yahoo Finance • 2 months ago
Stocks Settle Lower as Bond Yields Rise
The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Monday closed down by -0.43%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.... Full story
Yahoo Finance • 2 months ago
Stocks Turn Mixed on Strength in the Magnificent Seven Megacaps
The S&P 500 Index ($SPX) (SPY) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI) (DIA) is down by -0.49%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +0.03%. September E-mini S&P futures (ESU25) are down -0.13%, and Sep... Full story
Yahoo Finance • 2 months ago
Axogen stock falls after FDA extends review timeline for nerve graft
Investing.com -- Axogen (NASDAQ:AXGN) stock declined 9% after the U.S. Food and Drug Administration (FDA) extended its review timeline for the company’s Avance Nerve Graft by three months. The FDA has pushed the Prescription Drug User Fee... Full story
Yahoo Finance • 2 months ago
Stocks Pressured by Rising Bond Yields
The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futu... Full story
Yahoo Finance • 2 months ago
Axogen falls 16% after FDA delays Avance Nerve Graft decision to December
Axogen (NASDAQ:AXGN [https://seekingalpha.com/symbol/AXGN]) shares fell 16% in premarket trading after [https://seekingalpha.com/pr/20209800-axogen-provides-update-on-fda-review-timeline-for-avance-nerve-graft] the company announced that t... Full story
Yahoo Finance • 2 months ago
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
ALACHUA, Fla. and TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Biolo... Full story
Yahoo Finance • 2 months ago
Axogen (AXGN) Slid on a Weaker Than Expected Gross Margin
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. During the quarter, equity markets experienced a significant re... Full story
Yahoo Finance • 2 months ago
Raymond James Slashes PT on Axogen (AXGN) to $20 From $21
Axogen, Inc. (NASDAQ:AXGN) is one of the best medical device stocks to buy according to analysts. On August 6, Raymond James analyst Jayson Bedford lowered the firm’s price target on Axogen, Inc. (NASDAQ:AXGN) to $20 from $21, keeping an O... Full story
Yahoo Finance • 2 months ago
Axogen Inc (NASDAQ:AXGN) Surges 15.8% After Q2 2025 Earnings Beat and Raised Guidance
AXOGEN INC (NASDAQ:AXGN [https://www.chartmill.com/stock/quote/AXGN]) BEATS Q2 2025 ESTIMATES, RAISES FULL-YEAR GUIDANCE Axogen Inc reported its second-quarter 2025 financial results, delivering revenue and earnings per share (EPS) that e... Full story
Yahoo Finance • 2 months ago
These stocks are moving in today's pre-market session
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. [premarket] GAINERS TICKER CHANGE COMMENT AIP [https://www.chartmill.com/stock/quote/AIP/... Full story
Yahoo Finance • 2 months ago
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include: * Pfizer (PFE [https://seekingalpha.com/symbol/PFE]) * Caterpillar (CAT [https://seekingalpha.com/symbol/CAT]) * BP p.l.c. (BP [https://seekingalpha.com/symbol/BP]) * Org... Full story
Yahoo Finance • 2 months ago
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced tha... Full story
Yahoo Finance • 3 months ago
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced tha... Full story
Yahoo Finance • 3 months ago
AxoGen's SWOT analysis: nerve repair leader's stock poised for growth
AxoGen, Inc. (NASDAQ:AXGN), a leader in peripheral nerve injury solutions with a market capitalization of approximately $498 million, has been making significant strides in the medical technology sector. The company’s innovative products a... Full story
Yahoo Finance • 7 months ago
Axogen, Inc. To Host Analyst & Investor Day on March 4th
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, will hold its Analyst & Investor Day o... Full story
Yahoo Finance • 8 months ago
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 20... Full story
Yahoo Finance • 2 years ago
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Axogen, Inc. ALACHUA and TAMPA, Fla., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making Inducemen... Full story
Yahoo Finance • 2 years ago
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference
ALACHUA and TAMPA, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, Chairman... Full story
Yahoo Finance • 2 years ago
Q3 2023 AxoGen Inc Earnings Call
Participants Karen Zaderej; Chairman of the Board, President, & CEO; Axogen, Inc. Pete Mariani; CFO & EVP; Axogen, Inc. Adanna Alexander; IR; Russo Partners LLC Mike Sarcone; Analyst; Jefferies Group Mike Kratky; Analyst; Leerink Part... Full story
